Pharmacoeconomic analysis of pembrolizumab in combination with chemotherapy as the first line of advances non-squamous non-small cell lung cancer treatment

Autor:	D.D. Sakaeva Sakaeva, M.V. Zhuravleva Zhuravleva, V.A. Rogov Rogov, S.K. Zyryanov Zyryanov, M. Yu. Frolov
Rok vydání:	2018
Předmět:	Oncology Chemotherapy medicine.medical_specialty business.industry First line medicine.medical_treatment Pembrolizumab medicine.disease Non squamous Internal medicine medicine Non small cell Lung cancer business
Zdroj:	Pharmateca. :105-114
ISSN:	2414-9128
DOI:	10.18565/pharmateca.2018.12.105-114
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::2a0d7b2dbd37afd02cfd09a94ca9627e https://doi.org/10.18565/pharmateca.2018.12.105-114 Zobrazit plný text záznamu